Guinea
The latest on Guinea, summarized bottom line first from credible sources: what happened, why it matters and what happens next.
Latest
Rio Tinto agrees to pay $250 million toward Panguna mine cleanup
Rio Tinto has agreed to pay US$250 million to begin repairing the abandoned Panguna mine site in Bougainville, The Guardian reports. The mine closed in 1989 after protests over environmental damage and the distribution of profits; the unrest led to a decade-long civil war, the report says.
Earlier coverage
At least 10 killed in clashes over gold-mining ban in northeastern Guinea
At least 10 people were killed in clashes with security forces in Guinea’s northeastern Siguiri region after a ban on artisanal gold mining, according to reports citing the country’s Ministry of Territorial Administration. The ban took effect Nov. 2 over environmental concerns, Al Jazeera reported.
US-funded vaccine trial in Guinea-Bissau cancelled after ethical criticism
A US-funded vaccine trial involving babies in Guinea-Bissau was cancelled after criticism that half the infants would not receive the vaccine. The trial was condemned as “unethical” and “neocolonial,” according to the BBC; reporting so far gives no further details about the study or its status.
Taiwan says it will close representative office in Papua New Guinea
Taiwan says it will close its representative office in Papua New Guinea and stop buying liquefied natural gas from Port Moresby, according to Al Jazeera, which reports that Taiwan blames China.
Drought in Papua New Guinea brings food, power and health-service disruption
A severe drought linked by The Guardian to El Niño is affecting as many as 8 million people in Papua New Guinea, with reported food and water shortages, power outages, and disruptions to schools and health clinics. A coalition of groups calls it a national crisis and says there is no coordinated plan to protect vulnerable communities.
House Democrats seek CDC answers on Guinea-Bissau hepatitis B trial
Top House Democrats asked the CDC for answers about its funding of a hepatitis B clinical trial in Guinea-Bissau, The Hill reports. The CDC awarded Danish researchers $1.6 million last year for the study; reporting so far does not describe the study’s design or the lawmakers’ specific concerns.
Guinea-Bissau blocks planned hepatitis B vaccine study
The planned newborn hepatitis B vaccine study in Guinea-Bissau will not proceed after the government refused to authorize it, the lead researcher said. The announcement follows a police search of the research project’s offices and seizure of vaccine doses.
Guinea-Bissau postpones December elections indefinitely
Guinea-Bissau has postponed elections scheduled for December 6, with no new date announced. The delay leaves the country’s return to civilian rule uncertain, according to DW.
Guinea-Bissau says it has not approved newborn hepatitis B study
Guinea-Bissau’s health minister says the government did not authorize a proposed Danish-led hepatitis B study in newborns. The Guardian reports that the study would track broader health outcomes rather than test vaccine safety or effectiveness.
Guinea-Bissau approves trial that will withhold hepatitis B vaccine from some newborns
A trial approved in Guinea-Bissau will withhold the recommended hepatitis B vaccine dose from some newborns, The Guardian reports. The article does not give the trial’s size, duration or other design details.
M 6.4 earthquake near 49 km NNE of Kainantu, Papua New Guinea
USGS records a M 6.4 earthquake near 49 km NNE of Kainantu, Papua New Guinea at 2026-09-20T09:17:35.624Z. The USGS event feed does not carry a tsunami flag.